vs
CADIZ INC（CDZI）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是CADIZ INC的1.8倍（$9.1M vs $5.1M），CADIZ INC同比增速更快（7.0% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-8.2M），过去两年CADIZ INC的营收复合增速更高（113.0% vs -6.7%）
Cadiz Inc是一家总部位于美国的自然资源与可持续发展企业，核心业务包括水资源管理、农业用地运营及可再生能源项目开发，主要在加利福尼亚州开展业务，为市政、农业及商业客户提供稳定的供水解决方案与土地管护服务。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
CDZI vs PLX — 直观对比
营收规模更大
PLX
是对方的1.8倍
$5.1M
营收增速更快
CDZI
高出57.0%
-49.9%
自由现金流更多
PLX
多$9.9M
$-8.2M
两年增速更快
CDZI
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.1M | $9.1M |
| 净利润 | — | $-5.5M |
| 毛利率 | 33.0% | 49.4% |
| 营业利润率 | -145.4% | -51.1% |
| 净利率 | — | -60.3% |
| 营收同比 | 7.0% | -49.9% |
| 净利润同比 | — | -184.8% |
| 每股收益（稀释后） | — | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDZIPLX
| Q4 25 | $5.1M | $9.1M | ||
| Q3 25 | $4.1M | $17.9M | ||
| Q2 25 | $4.1M | $15.7M | ||
| Q1 25 | $3.0M | $10.1M | ||
| Q4 24 | $4.8M | $18.2M | ||
| Q3 24 | $3.2M | $18.0M | ||
| Q2 24 | $513.0K | $13.5M | ||
| Q1 24 | $1.1M | — |
净利润CDZIPLX
| Q4 25 | — | $-5.5M | ||
| Q3 25 | $-7.1M | $2.4M | ||
| Q2 25 | $-7.7M | $164.0K | ||
| Q1 25 | $-9.6M | $-3.6M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | $-6.8M | $3.2M | ||
| Q2 24 | $-8.9M | $-2.2M | ||
| Q1 24 | $-6.8M | — |
毛利率CDZIPLX
| Q4 25 | 33.0% | 49.4% | ||
| Q3 25 | 27.3% | 53.4% | ||
| Q2 25 | 35.4% | 62.5% | ||
| Q1 25 | 29.7% | 19.1% | ||
| Q4 24 | 36.1% | 78.7% | ||
| Q3 24 | 25.3% | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | 10.4% | — |
营业利润率CDZIPLX
| Q4 25 | -145.4% | -51.1% | ||
| Q3 25 | -118.0% | 11.9% | ||
| Q2 25 | -140.0% | 7.5% | ||
| Q1 25 | -255.0% | -41.0% | ||
| Q4 24 | -139.5% | 39.6% | ||
| Q3 24 | -147.9% | 22.2% | ||
| Q2 24 | -1354.6% | -18.0% | ||
| Q1 24 | -437.8% | — |
净利率CDZIPLX
| Q4 25 | — | -60.3% | ||
| Q3 25 | -170.5% | 13.2% | ||
| Q2 25 | -187.3% | 1.0% | ||
| Q1 25 | -324.7% | -35.8% | ||
| Q4 24 | — | 35.6% | ||
| Q3 24 | -210.7% | 18.0% | ||
| Q2 24 | -1729.4% | -16.4% | ||
| Q1 24 | -611.1% | — |
每股收益（稀释后）CDZIPLX
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.6M | $14.7M |
| 总债务越低越好 | $72.7M | — |
| 股东权益账面价值 | $23.3M | $48.2M |
| 总资产 | $140.9M | $82.3M |
| 负债/权益比越低杠杆越低 | 3.13× | — |
8季度趋势，按日历期对齐
现金及短期投资CDZIPLX
| Q4 25 | $8.6M | $14.7M | ||
| Q3 25 | $4.4M | $13.6M | ||
| Q2 25 | $13.2M | $17.9M | ||
| Q1 25 | $21.6M | $19.5M | ||
| Q4 24 | $17.3M | $19.8M | ||
| Q3 24 | $3.3M | $27.4M | ||
| Q2 24 | $10.1M | $23.4M | ||
| Q1 24 | $19.2M | — |
总债务CDZIPLX
| Q4 25 | $72.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $56.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CDZIPLX
| Q4 25 | $23.3M | $48.2M | ||
| Q3 25 | $27.7M | $52.9M | ||
| Q2 25 | $35.6M | $49.9M | ||
| Q1 25 | $44.0M | $45.2M | ||
| Q4 24 | $34.0M | $43.2M | ||
| Q3 24 | $20.7M | $32.4M | ||
| Q2 24 | $27.6M | $28.6M | ||
| Q1 24 | $36.6M | — |
总资产CDZIPLX
| Q4 25 | $140.9M | $82.3M | ||
| Q3 25 | $128.0M | $82.3M | ||
| Q2 25 | $136.4M | $78.5M | ||
| Q1 25 | $145.6M | $73.9M | ||
| Q4 24 | $134.5M | $73.4M | ||
| Q3 24 | $112.6M | $61.6M | ||
| Q2 24 | $118.1M | $91.5M | ||
| Q1 24 | $118.1M | — |
负债/权益比CDZIPLX
| Q4 25 | 3.13× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.67× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.9M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-8.2M | $1.6M |
| 自由现金流率自由现金流/营收 | -162.2% | 17.8% |
| 资本支出强度资本支出/营收 | 26.1% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-26.5M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流CDZIPLX
| Q4 25 | $-6.9M | $2.0M | ||
| Q3 25 | $-7.0M | $-3.7M | ||
| Q2 25 | $-1.4M | $-5.2M | ||
| Q1 25 | $-3.6M | $-5.1M | ||
| Q4 24 | $-6.2M | $4.0M | ||
| Q3 24 | $-5.4M | $4.1M | ||
| Q2 24 | $-7.1M | $-3.6M | ||
| Q1 24 | $-2.9M | — |
自由现金流CDZIPLX
| Q4 25 | $-8.2M | $1.6M | ||
| Q3 25 | $-7.5M | $-4.2M | ||
| Q2 25 | $-5.9M | $-5.7M | ||
| Q1 25 | $-4.9M | $-5.4M | ||
| Q4 24 | $-6.6M | $3.6M | ||
| Q3 24 | $-5.4M | $4.0M | ||
| Q2 24 | $-7.3M | $-3.8M | ||
| Q1 24 | $-3.1M | — |
自由现金流率CDZIPLX
| Q4 25 | -162.2% | 17.8% | ||
| Q3 25 | -179.8% | -23.7% | ||
| Q2 25 | -142.2% | -36.2% | ||
| Q1 25 | -167.0% | -53.0% | ||
| Q4 24 | -139.4% | 19.6% | ||
| Q3 24 | -168.8% | 22.4% | ||
| Q2 24 | -1431.6% | -28.1% | ||
| Q1 24 | -272.9% | — |
资本支出强度CDZIPLX
| Q4 25 | 26.1% | 4.4% | ||
| Q3 25 | 10.8% | 2.8% | ||
| Q2 25 | 109.3% | 2.8% | ||
| Q1 25 | 43.6% | 3.0% | ||
| Q4 24 | 8.7% | 2.3% | ||
| Q3 24 | 1.7% | 0.5% | ||
| Q2 24 | 54.8% | 1.3% | ||
| Q1 24 | 16.6% | — |
现金转化率CDZIPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDZI
| Water Treatment | $4.4M | 86% |
| Other | $724.0K | 14% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
